Cancer 
        Digest        

A new type of blood test is showing promise of being able to detect multiple liver diseases including cancer by examining fragments of DNA that circulate in the blood.

A small clinical trial showed proof of concept of vaccine prevention of pancreatic cancer in high-risk individuals. (Image generated by WIX AI) CANCER DIGEST – July 19, 2026 – That’s the question asked by researchers led by Neeha Zaidi, MD, at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University. Approximately 10 percent of pancreatic cancers are associated with genetic predisposition caused by mutations in specific cancer susceptibility genes that are pa

In a clinical trial, an experimental oral targeted medication nearly doubled overall survival in pancreatic cancer patients with a specific genetic mutation, compared to standard chemotherapy.

Scientists have discovered a new and previously undescribed virus that infects gut bacteria in patients with colorectal cancer.

atients given a course of immunotherapy prior to surgery for colon cancer remain cancer-free nearly three years later.

A blood test that accurately detects early-stage pancreatic cancer could improve survival rate. Image credit – National Institutes of Health NIH-funded study could diagnose pancreatic cancer at earlier, more treatable stage CANCER DIGEST – April 18, 2026 – A new blood test could detect pancreatic cancer much earlier than is currently possible, making treatment at an early stage of the cancer possible, according to a new study published in the Jan. 29, 2026 journal Clinical Ca

Short intensive periods of physical activity can unleash several molecules in the blood linked to reducing inflammation and improving blood vessel function and metabolism, which can slow colorectal cancer growth.

Colon cancer patients taking GLP-1 medications were less than half as likely to die within five years compared to those who weren’t on the drugs. – Image credit UC San Diego Today CANCER DIGEST – Nov. 15, 2025 – An analysis of data from nearly 7,000 colon cancer patients treated at cancer centers throughout California showed that patients who were taking a class of drug called glucagon-like peptide-1 (GLP-1) were more likely to survive compared to similar patients who were no

A novel cancer vaccine designed to rally the body's immune system against a common cancer-driving gene mutation.

Deaths from obesity-linked cancers have tripled in two decades – Photo credit Unsplash Media CANCER DIGEST – July 20, 2025 – Cancers...